APA Citation

Shapiro, A. D. (2021). Concizumab: A novel anti-TFPI therapeutic for hemophilia. Blood Adv.

Citação norma Chicago

Shapiro, Amy D. "Concizumab: A Novel Anti-TFPI Therapeutic for Hemophilia." Blood Adv 2021.

MLA Citation

Shapiro, Amy D. "Concizumab: A Novel Anti-TFPI Therapeutic for Hemophilia." Blood Adv 2021.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.